American International Group’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-62,439
| Closed | -$161K | – | 18 |
|
|
2024
Q1 | $161K | Sell |
62,439
-536
| -0.9% | -$1.38K | ﹤0.01% | 2269 |
|
|
2023
Q4 | $157K | Buy |
62,975
+683
| +1% | +$1.71K | ﹤0.01% | 2299 |
|
|
2023
Q3 | $126K | Buy |
62,292
+2,214
| +4% | +$4.49K | ﹤0.01% | 2374 |
|
|
2023
Q2 | $138K | Buy |
60,078
+5,246
| +10% | +$12.1K | ﹤0.01% | 2381 |
|
|
2023
Q1 | $166K | Buy |
54,832
+1,091
| +2% | +$3.31K | ﹤0.01% | 2220 |
|
|
2022
Q4 | $125K | Buy |
53,741
+2,472
| +5% | +$5.76K | ﹤0.01% | 2401 |
|
|
2022
Q3 | $98K | Buy |
51,269
+725
| +1% | +$1.39K | ﹤0.01% | 2563 |
|
|
2022
Q2 | $137K | Buy |
50,544
+5,312
| +12% | +$14.4K | ﹤0.01% | 2407 |
|
|
2022
Q1 | $135K | Buy |
45,232
+2,533
| +6% | +$7.56K | ﹤0.01% | 2463 |
|
|
2021
Q4 | $166K | Sell |
42,699
-1,278
| -3% | -$4.97K | ﹤0.01% | 2466 |
|
|
2021
Q3 | $189K | Buy |
43,977
+214
| +0.5% | +$920 | ﹤0.01% | 2464 |
|
|
2021
Q2 | $133 | Buy |
+43,763
| New | +$133 | ﹤0.01% | 2755 |
|
|
2019
Q2 | – | Sell |
-22,516
| Closed | -$81K | – | 3102 |
|
|
2019
Q1 | $81K | Sell |
22,516
-729
| -3% | -$2.62K | ﹤0.01% | 2709 |
|
|
2018
Q4 | $89K | Sell |
23,245
-180
| -0.8% | -$689 | ﹤0.01% | 2658 |
|
|
2018
Q3 | $221K | Buy |
23,425
+423
| +2% | +$3.99K | ﹤0.01% | 2362 |
|
|
2018
Q2 | $168K | Buy |
+23,002
| New | +$168K | ﹤0.01% | 2463 |
|
|
2015
Q2 | – | Sell |
-8,200
| Closed | -$143K | – | 5128 |
|
|
2015
Q1 | $143K | Buy |
8,200
+4,150
| +102% | +$72.5K | ﹤0.01% | 3259 |
|
|
2014
Q4 | $61.4K | Buy |
4,050
+1,978
| +95% | +$30K | ﹤0.01% | 3870 |
|
|
2014
Q3 | $43.8K | Buy |
+2,072
| New | +$43.8K | ﹤0.01% | 4029 |
|